Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Operating Income: 2009-2025

Historic Operating Income for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $5.3 million.

  • Lifecore Biomedical's Operating Income rose 147.88% to $5.3 million in Q2 2025 from the same period last year, while for May 2025 it was -$17.2 million, marking a year-over-year decrease of 95.01%. This contributed to the annual value of -$17.2 million for FY2025, which is 94.99% down from last year.
  • Per Lifecore Biomedical's latest filing, its Operating Income stood at $5.3 million for Q2 2025, which was up 159.00% from -$9.0 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Operating Income ranged from a high of $5.3 million in Q2 2025 and a low of -$11.6 million during Q3 2024.
  • For the 3-year period, Lifecore Biomedical's Operating Income averaged around -$3.9 million, with its median value being -$4.2 million (2023).
  • In the last 5 years, Lifecore Biomedical's Operating Income soared by 173.94% in 2021 and then crashed by 13,302.74% in 2022.
  • Lifecore Biomedical's Operating Income (Quarterly) stood at $3.7 million in 2021, then tumbled by 245.04% to -$5.4 million in 2022, then skyrocketed by 72.29% to -$1.5 million in 2023, then crashed by 32.10% to -$2.0 million in 2024, then skyrocketed by 147.88% to $5.3 million in 2025.
  • Its Operating Income stands at $5.3 million for Q2 2025, versus -$9.0 million for Q1 2025 and -$2.0 million for Q4 2024.